FDAnews Drug Daily Bulletin

ADNEXUS THERAPEUTICS CLOSES $27 MILLION VENTURE CAPITAL

June 27, 2006
A A

Adnexus Therapeutics, Inc. (formerly Compound Therapeutics, Inc.), announced today it has closed $27M in a Series B financing. The financing was led by Venrock Associates, which joined founding investors Atlas Venture, Flagship Ventures, and Polaris Venture Partners in the round. As part of this financing Anders Hove, M.D., of Venrock Associates will join the Adnexus Board of Directors. American Venture Magazine (http://www.americanventuremagazine.com/news.php?newsid=1192)